慢性阻塞性肺疾病合并骨质疏松的相关危险因素分析
Analysis of Related Risk Factors of Chronic Obstructive Pulmonary Disease Complicated with Osteoporosis
DOI: 10.12677/ACM.2022.123272, PDF,   
作者: 张 丽:青海大学,青海 西宁;杨青岩:青海大学附属医院老年医学科,青海 西宁
关键词: 慢性阻塞性肺疾病骨质疏松危险因素Chronic Obstructive Pulmonary Disease Osteoporosis Risk Factors
摘要: 慢性阻塞性肺疾病(Chronic obstructive pulmonary disease, COPD)简称慢阻肺,是一种常见的、可以预防和治疗的疾病。常引起多种肺外疾病,而骨质疏松便是多种肺外疾病中较为突出且严重的一种疾病。目前COPD并发骨质疏松尚未得到患者及临床医生的足够重视,若COPD合并骨质疏松未被及时发现及重视,将会导致骨折等更加严重的并发症。本文就COPD与骨质疏松的关系、COPD合并骨质疏松的危险因素及对COPD合并骨质疏松患者的相关治疗进行综述。
Abstract: Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease. Osteoporosis is a prominent and serious disease in a variety of extrapulmonary diseases. At present, patients and clinicians have not paid enough attention to COPD combined with osteoporosis. If COPD combined with osteoporosis is not recognized and paid attention to in time, it will lead to fractures and other more serious complications. This article reviews the relationship between COPD and osteoporosis, the risk factors of COPD combined with osteoporosis and the treatment of patients with COPD combined with osteoporosis.
文章引用:张丽, 杨青岩. 慢性阻塞性肺疾病合并骨质疏松的相关危险因素分析[J]. 临床医学进展, 2022, 12(3): 1888-1892. https://doi.org/10.12677/ACM.2022.123272

参考文献

[1] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版) [J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.
[2] Li, C.L., Lin, M.H., Chen, P.S., Tsai, Y.C., Shen, L.S., Kuo, H.C. and Liu, S.F. (2020) Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 15, 389-395. [Google Scholar] [CrossRef
[3] 林展增. 中国慢性阻塞性肺疾病流行病学研究进展[J]. 河北北方学院学报(自然科学版), 2020, 36(8): 49-51+56.
[4] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017) [J]. 中国实用内科杂志, 2018, 38(2): 127-150.
[5] Inoue, D., Watanabe, R. and Okazaki, R. (2016) COPD and Osteoporosis: Links, Risks, and Treatment Challenges. International Journal of Chronic Obstructive Pulmonary Disease, 11, 637-648. [Google Scholar] [CrossRef
[6] Graat-Verboom, L., Wouters, E.F., Smeenk, F.W., van den Borne, B.E., Lunde, R. and Spruit, M.A. (2009) Current Status of Research on Osteoporosis in COPD: A Systematic Review. European Respiratory Journal, 34, 209-218. [Google Scholar] [CrossRef] [PubMed]
[7] 杨生岳, 戴胜归, 冯恩志. 慢性阻塞性肺疾病合并心血管疾病的研究进展[J]. 中华肺部疾病杂志(电子版), 2014, 7(3): 81-83.
[8] 朱峥, 高秋静. 慢性阻塞性肺疾病与骨质疏松的研究进展[J]. 中国医师杂志, 2014(z2): 355-357.
[9] Sarkar, M., Bhardwaj, R., Madabhavi, I. and Khatana, J. (2015) Osteoporosis in Chronic Obstructive Pulmonary Disease. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 9, 5-21. [Google Scholar] [CrossRef
[10] Faner, R., Rojas, M., Macnee, W., Agustí, A. (2012) Abnormal Lung Aging in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 186, 306-313. [Google Scholar] [CrossRef
[11] Lee, J., Sandford, A., Man, P. and Sin, D.D. (2011) Is the Aging Process Accelerated in Chronic Obstructive Pulmonary Disease? Current Opinion in Pulmonary Medicine, 17, 90-97. [Google Scholar] [CrossRef
[12] Barnes, P.J. (2016) Inflammatory Mechanisms in Patients with Chronic Obstructive Pulmonary Disease. Journal of Allergy and Clinical Immunology, 138, 16-27. [Google Scholar] [CrossRef] [PubMed]
[13] 王凯, 宋敏, 文皓楠, 海云翔, 巩彦龙. 从OPG/RANK/RANKL信号转导系统探讨老年性骨质疏松的发病机制[J]. 中国骨质疏松杂志, 2020, 26(6): 910-914.
[14] Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., Cua, D.J., Takayanagi, H. (2006) Th17 Functions as an Osteoclastogenic Helper T Cell Subset That Links T Cell Activation and Bone Destruction. Journal of Experimental Medicine, 203, 2673-2682. [Google Scholar] [CrossRef] [PubMed]
[15] 袁红, 李俊, 翁育清, 欧阳剑锋. 唑来膦酸治疗COPD患者骨质疏松症的疗效及对肺功能影响的分析[J]. 中国骨质疏松杂志, 2019, 25(3): 358-361.